Hanmi, Sanfer Partner to Bring GLP-1 Therapy to Mexico Hanmi Pharmaceutical has signed an exclusive distribution agreement with Mexico-based Laboratorios Sanfer to introduce efpeglenatide, a GLP-1 therapy for obesity, alongside Hanmis Dapalon Family diabetes treatments, marking a step in the South Korean companys global expansion strategy focused on metabolic diseases
HSPB9 and HSPB10 are predominantly expressed in the testes
Tschp M, Nogueiras R, Ahrn B
Note that some parents did not complete Section IV of Health/Physical Behavior due to a clerical error
The dilemma is clear: cover costs and risk uncontrolled spending, or limit access and face frustrated employees and higher downstream costs
The seed cake -- the part of the seed left after oil is taken out -- is full of potassium, phosphorus, and calcium